K. Tuesday Werner DNP, AGACNP, FNP-BC, AFAASLD (She/Her)

Family Care, Gastroenterology

NP Transplant Hepatology

Summary

K. Tuesday Werner is dual Nurse Practitioner based in Phoenix, AZ, with specialties in Liver Transplantation and Hepatology. Tuesday Werner obtained advanced nursing education, culminating in a doctorate from Arizona State University, a Family Nurse Practitioner degree from the University of Phoenix and Acute Care Nurse Practitioner at Grand Canyon University. Tuesday Werner is employed at Mayo Clinic Hospital as Advanced Practice Provider. With expertise in viral hepatitis, liver transplantation, and Hepatology. She has contributed to significant research, including publications on acute liver failure and hepatitis C treatment, heavily cited in the fields of hepatology. Tuesday Werner's accolades include the role of Co-chair for the Mayo Employees Resource Group Asian and Assistant Professor at Mayo Clinic School of Medicine.

PubMed

28 citations
Acute liver failure associated with Garcinia cambogia use.
Rebecca L. Corey, K. Tuesday Werner, Andrew C. Singer, Adyr A. Moss, Maxwell L. Smith
Annals of Hepatology. 2015-12-01
49 citations
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
Bashar Aqel, Surakit Pungpapong, Michael D. Leise, K. Tuesday Werner, Amy E. Chervenak
Hepatology. 2015-10-01
149 citations
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant.
Surakit Pungpapong, Bashar Aqel, Michael D. Leise, K. Tuesday Werner, Jennifer L. Murphy
Hepatology. 2015-06-01

Journal Articles

Primary Care Management of Hepatic Encephalopathy: A Common Cirrhosis Complication
Amanda Chaney MSN, FNP-BCK. Tuesday Werner DNP, NP-CTami Kipple ARNP, Journal of Nurse Practitioners, 2/1/2015
Role of Nurse Practitioners in the Management of Cirrhotic Patients
Kristina Tuesday Werner, DNP, FNP-C, Shari Terese Perez, MSN, ANP, The Journal of Nurse Practitioners, 11/1/2012

Abstracts/Posters

The use of simeprevir and sofosbuvir to treat HCV G1 in the Liver Transplant Setting: The experience in 3 US Centers.
Bashar Aqel, Surakit Pungpapong, K Tuesday Werner, Amy E. Chervenak, Jorge Rakela, Kymberly D. Watt, Michael D. Leise, Jennifer L. Murphy, Tanisha M. Henry, Kristen Ry..., American Association for the Study of Liver Disease, Boston, Massachusetts, 11/11/2014
Multicenter Experience using Sofosbuvir and Simeprevir to Treat HCV Genotype 1 after Liver Transplantation.
Surakit Pungpapong, K Tuesday Werner, Bashar Aqel, Michael D. Leise, Jennifer L. Murphy, Tanisha M. Henry, Kristen Ryland, Amy E. Chervenak, Kymberly D. Watt, Hugo E. ..., American Association for the Study of Liver Disease, Boston, Massachusetts, 11/7/2014
Treatment of HCV in the SOF Era: Experience in Difficult to Treat Patients in a U.S. Liver Transplant Center Poster Presentation
Werner KT, Chervenak A, Hartel L, Aqel B, Balan V, Byrne T, Carey E, Vargas H, Rakela J., American Association for the Study of Liver Diseases (AASLD), Boston, MA, 11/6/2014